James Garnsey
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
Papers in
-
- Ubiquitin and proteasome pathways 6
- Protein Degradation and Inhibitors 2
- Cancer-related gene regulation 1
- Cell death mechanisms and regulation 1
- Histone Deacetylase Inhibitors Research 1
-
- NF-κB Signaling Pathways 1
- Cancer, Hypoxia, and Metabolism 1
- Co-authors
- Francis J. Giles (1 shared paper)Ernest Medina (1 shared paper)Steffan T. Nawrocki (1 shared paper)Swaminathan P. Iyer (1 shared paper)Michael O’Dwyer (1 shared paper)Ronan Swords (1 shared paper)Devalingam Mahalingam (1 shared paper)Kevin R. Kelly (1 shared paper)
- Journals
- Blood (3 papers)Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesJapanIreland
In The Last Decade
James Garnsey
7 papers receiving 511 citations
Peers
Comparison fields: 5 of 49
- Hematology 87
- Molecular Biology 444
- Oncology 176
- Cancer Research 84
- Genetics 43
Countries citing papers authored by James Garnsey
This map shows the geographic impact of James Garnsey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Garnsey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Garnsey more than expected).
Fields of papers citing papers by James Garnsey
This network shows the impact of papers produced by James Garnsey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Garnsey. The network helps show where James Garnsey may publish in the future.
Co-authors
The 25 scholars most cited alongside James Garnsey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 270 | |
| 2 | 2010 | 222 | |
| 3 | 2015 | 14 | |
| 4 | 2011 | 5 | |
| 5 | 2009 | 2 | |
| 6 | 2019 | 1 | |
| 7 | 2017 | 1 |
About James Garnsey
James Garnsey is a scholar working on Molecular Biology, Cancer Research, Biotechnology, Oncology and Immunology, having authored 7 papers that have together received 515 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (2 papers), Cancer Research and Treatments (2 papers), Cancer-related gene regulation (1 paper), Cell death mechanisms and regulation (1 paper), NF-κB Signaling Pathways (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Hematology (87 citations), Molecular Biology (444 citations), Oncology (176 citations), Cancer Research (84 citations) and Genetics (43 citations). James Garnsey has collaborated with scholars based in United States, Japan and Ireland. Frequent co-authors include Francis J. Giles, Ernest Medina, Steffan T. Nawrocki, Swaminathan P. Iyer, Michael O’Dwyer, Ronan Swords, Devalingam Mahalingam, Kevin R. Kelly, Peter G. Smith and Jennifer S. Carew. Their work appears in journals such as Blood, Cancer Research, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.